Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease (NCT06799039)

🧪 Interventions in This Study

• Xylitol (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Brigham and Women's Hospital — Boston, Massachusetts

📞 Contact the Study Coordinator

Phone: (617) 525-7322

Email: hjcabral@bwh.harvard.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Inflammatory Bowel Disease (IBD)

• Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease — Nashville, Tennessee
• Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease — Boston, Massachusetts
• VR Therapies for IBD — Los Angeles, California
• Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE) in Participants With Inflammatory Bowel Disease (IBD) — Nashville, Tennessee
• Evaluation of the SMART IBD App in Pediatric IBD — Cincinnati, Ohio

Explore by condition: All Inflammatory Bowel Disease (IBD) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.